{"id":"W4416086893","doi":"10.1182/bloodadvances.2025016845","title":"A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Ipsen; Mallinckrodt Pharmaceuticals; Seagen; National Institutes of Health; Incyte; BeiGene; Genentech; AstraZeneca","keywords":"Lenalidomide; Blinatumomab; Concomitant; Adverse effect; Phases of clinical research; Toxicity; Lymphoma; Neurotoxicity","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004456186,0.0002035506,0.0007866092,0.001014962,0.0000574774,0.00001490619,0.0001496365,0.00008543303,0.000159795],"category_scores_gemma":[0.0002399541,0.0001774386,0.0001182252,0.002141463,0.0001661052,0.000100652,0.0001199729,0.0002499533,0.000003114694],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007061047,"about_ca_system_score_gemma":0.0001496513,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000157569,"about_ca_topic_score_gemma":0.0003862236,"domain_scores_codex":[0.9981231,0.0002052555,0.0005076387,0.0004728431,0.0004130565,0.000278105],"domain_scores_gemma":[0.998485,0.000705688,0.0001583033,0.0004111051,0.0001353883,0.0001045479],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.01557352,0.1614813,0.5250185,0.0006669434,0.004875793,0.0008793194,0.00667144,0.0004033155,0.1771536,0.0001155083,0.0001223985,0.1070384],"study_design_scores_gemma":[0.4831006,0.0252352,0.2638576,0.0007433105,0.009366643,0.00003589888,0.01534448,0.002056342,0.1930216,0.0005222859,0.005842637,0.0008733431],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848545,0.008581989,0.00003266428,0.00007155662,0.00006207179,0.000935604,0.00001032721,0.00002837788,0.005422871],"genre_scores_gemma":[0.9946317,0.0005951137,0.0001393998,0.0000529449,0.00002606216,0.00004390438,0.000008650034,0.00001512194,0.004487085],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4675271,"threshold_uncertainty_score":0.7235736,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01619469634600543,"score_gpt":0.3483985157154631,"score_spread":0.3322038193694576,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}